BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1051 related articles for article (PubMed ID: 11373099)

  • 21. Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Baratti D; Kusamura S; Martinetti A; Seregni E; Laterza B; Oliva DG; Deraco M
    Ann Surg Oncol; 2007 Aug; 14(8):2300-8. PubMed ID: 17510772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review of patients with peritoneal malignancy treated with peritonectomy and heated intraperitoneal chemotherapy.
    Hadi R; Saunders V; Utkina O; Clingan P; Kam P; Links M; Morris DL
    ANZ J Surg; 2006 Mar; 76(3):156-61. PubMed ID: 16626358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms.
    Yan TD; Bijelic L; Sugarbaker PH
    Ann Surg Oncol; 2007 Aug; 14(8):2289-99. PubMed ID: 17541772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?
    Sugarbaker PH
    Lancet Oncol; 2006 Jan; 7(1):69-76. PubMed ID: 16389186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study.
    Loungnarath R; Causeret S; Bossard N; Faheez M; Sayag-Beaujard AC; Brigand C; Gilly F; Glehen O
    Dis Colon Rectum; 2005 Jul; 48(7):1372-9. PubMed ID: 15909071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Elias D; Honoré C; Ciuchendéa R; Billard V; Raynard B; Lo Dico R; Dromain C; Duvillard P; Goéré D
    Br J Surg; 2008 Sep; 95(9):1164-71. PubMed ID: 18690633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei.
    Güner Z; Schmidt U; Dahlke MH; Schlitt HJ; Klempnauer J; Piso P
    Int J Colorectal Dis; 2005 Mar; 20(2):155-60. PubMed ID: 15503065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The second procedure combining complete cytoreductive surgery and intraperitoneal chemotherapy for isolated peritoneal recurrence: postoperative course and long-term outcome.
    Brouquet A; Goéré D; Lefèvre JH; Bonnet S; Dumont F; Raynard B; Elias D
    Ann Surg Oncol; 2009 Oct; 16(10):2744-51. PubMed ID: 19626375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study.
    Glehen O; Kwiatkowski F; Sugarbaker PH; Elias D; Levine EA; De Simone M; Barone R; Yonemura Y; Cavaliere F; Quenet F; Gutman M; Tentes AA; Lorimier G; Bernard JL; Bereder JM; Porcheron J; Gomez-Portilla A; Shen P; Deraco M; Rat P
    J Clin Oncol; 2004 Aug; 22(16):3284-92. PubMed ID: 15310771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique.
    Kusamura S; Younan R; Baratti D; Costanzo P; Favaro M; Gavazzi C; Deraco M
    Cancer; 2006 Mar; 106(5):1144-53. PubMed ID: 16456817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secondary cytoreduction and perioperative intraperitoneal chemotherapy after initial debulking of pseudomyxoma peritonei: a study of timing and the impact of malignant dedifferentiation.
    Chua TC; Al-Zahrani A; Saxena A; Liauw W; Zhao J; Morris DL
    J Am Coll Surg; 2010 Oct; 211(4):526-35. PubMed ID: 20729102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Italian Multicentric Phase II study on peritonectomy and intra peritoneal hyperthermic perfusion (IPHP) to treat patients with pseudomyxoma peritonei.
    Deraco M; De Simone M; Rossi CR; Cavaliere F; Di Filippo F; Vaira M; Piatti P; Kusamura S
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):35-9. PubMed ID: 16767904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study.
    Brigand C; Monneuse O; Mohamed F; Sayag-Beaujard AC; Isaac S; Gilly FN; Glehen O
    Ann Surg Oncol; 2006 Mar; 13(3):405-12. PubMed ID: 16485159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early results of surgery in 123 patients with pseudomyxoma peritonei from a perforated appendiceal neoplasm.
    Murphy EM; Sexton R; Moran BJ
    Dis Colon Rectum; 2007 Jan; 50(1):37-42. PubMed ID: 17115339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of two kinds of intraperitoneal chemotherapy following complete cytoreductive surgery of colorectal peritoneal carcinomatosis.
    Elias D; Benizri E; Di Pietrantonio D; Menegon P; Malka D; Raynard B
    Ann Surg Oncol; 2007 Feb; 14(2):509-14. PubMed ID: 17096054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin.
    Loggie BW; Fleming RA; McQuellon RP; Russell GB; Geisinger KR
    Am Surg; 2000 Jun; 66(6):561-8. PubMed ID: 10888132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma: non-mucinous tumour associated with an improved survival.
    Yan TD; Chu F; Links M; Kam PC; Glenn D; Morris DL
    Eur J Surg Oncol; 2006 Dec; 32(10):1119-24. PubMed ID: 16887321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraperitoneal treatment for peritoneal mucinous carcinomatosis of appendiceal origin after operative management: long-term follow-up of the Mayo Clinic experience.
    Schomas DA; Miller RC; Donohue JH; Gill S; Thurmes PJ; Haddock MG; Quevedo JF; Gunderson LL
    Ann Surg; 2009 Apr; 249(4):588-95. PubMed ID: 19300231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cytoreductive surgery and intraperitoneal hyperthermic-antiblastic therapy (HAPP) in peritoneal carcinomatosis].
    Vaira M; Scuderi S; Costamagna D; Barone R; Aghemo B; Mioli PR; De Simone M
    Minerva Chir; 2002 Oct; 57(5):597-605. PubMed ID: 12370661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10 years of experience from a single institution.
    Chua TC; Yan TD; Smigielski ME; Zhu KJ; Ng KM; Zhao J; Morris DL
    Ann Surg Oncol; 2009 Jul; 16(7):1903-11. PubMed ID: 19387742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.